{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:35Z","timestamp":1787020175181,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of The Peoples Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cellsig.2024.111355","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:51:20Z","timestamp":1724363480000},"page":"111355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Angiotensin II depends on hippo\/YAP signaling to reprogram angiogenesis and promote liver fibrosis"],"prefix":"10.1016","volume":"123","author":[{"given":"Yanan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0005","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111355_bb0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.cellsig.2024.111355_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13578-019-0363-2","article-title":"PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt\/\u03b2-catenin signaling pathway and aggravates liver fibrosis","volume":"9","author":"Rao","year":"2019","journal-title":"Cell Biosci."},{"issue":"12","key":"10.1016\/j.cellsig.2024.111355_bb0020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41419-019-2101-4","article-title":"MKL1 promotes endothelial-to-mesenchymal transition and liver fibrosis by activating TWIST1 transcription","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","article-title":"Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury","volume":"71","author":"Liu","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellsig.2024.111355_bb0030","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0035","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cellsig.2024.111355_bb0045","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2024.111355_bb0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/iub.1059","article-title":"The role of endothelial-mesenchymal transition in development and pathological process","volume":"64","author":"Lin","year":"2012","journal-title":"IUBMB Life"},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.tcm.2017.03.003","article-title":"Endothelial-to-mesenchymal transition: a novel therapeutic target for cardiovascular diseases","volume":"27","author":"Jackson","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0065","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/hep.27635","article-title":"Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis","volume":"61","author":"Kantari-Mimoun","year":"2015","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111355_bb0070","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.20193","article-title":"Angiogenesis in chronic inflammatory liver disease","volume":"39","author":"Medina","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"5","key":"10.1016\/j.cellsig.2024.111355_bb0075","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","article-title":"Vascular endothelial growth factor promotes fibrosis resolution and repair in mice","volume":"146","author":"Yang","year":"2014","journal-title":"Gastroenterology"},{"issue":"227","key":"10.1016\/j.cellsig.2024.111355_bb0080","doi-asserted-by":"crossref","first-page":"227ra34","DOI":"10.1126\/scitranslmed.3006927","article-title":"TGF-\u03b2 signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling","volume":"6","author":"Cooley","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cvr\/cvx253","article-title":"Endothelial-mesenchymal transition in atherosclerosis","volume":"114","author":"Souilhol","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2024.111355_bb0090","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41467-017-01169-0","article-title":"Dynamic regulation of canonical TGF\u03b2 signalling by endothelial transcription factor ERG protects from liver fibrogenesis","volume":"8","author":"Dufton","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2024.111355_bb0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3892\/ol.2020.12071","article-title":"Potential biomarkers Ang II\/AT1R and S1P\/S1PR1 predict the prognosis of hepatocellular carcinoma","volume":"20","author":"Ji","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cellsig.2024.111355_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fmolb.2020.00189","article-title":"Prognostic and immunological value of angiotensin-converting enzyme 2 in Pan-Cancer","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cellsig.2024.111355_bb0105","article-title":"The mechanisms of renin-angiotensin system in hepatocellular carcinoma: from the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures","volume":"141","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacotherapy Biomed. Pharmacotherapie"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111355_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.dld.2018.08.005","article-title":"ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: a pilot study","volume":"51","author":"Annicchiarico","year":"2019","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111355_bb0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23419","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.cellsig.2024.111355_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.07.013","article-title":"NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells","volume":"126","author":"Andueza","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2024.111355_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2018.05.005","article-title":"Redox signal-mediated TRPM2 promotes Ang II-induced adipocyte insulin resistance via ca(2+)-dependent CaMKII\/JNK cascade","volume":"85","author":"Gao","year":"2018","journal-title":"Metab. Clin. Exp."},{"issue":"11","key":"10.1016\/j.cellsig.2024.111355_bb0130","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/jgh.12988","article-title":"Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients","volume":"30","author":"Facciorusso","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.cellsig.2024.111355_bb0135","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1042\/CS20191235","article-title":"Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS","volume":"134","author":"Huang","year":"2020","journal-title":"Clin. Sci. (London, England:1979)"},{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2024.111355_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/MCB.26.1.77-87.2006","article-title":"Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65","volume":"26","author":"Morin-Kensicki","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111355_bb0150","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/acsptsci.1c00010","article-title":"Selective targeting of vascular endothelial YAP activity blocks EndMT and ameliorates unilateral ureteral obstruction-induced kidney fibrosis","volume":"4","author":"Ren","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.cellsig.2024.111355_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108639","article-title":"Targeted inhibition of the immunoproteasome blocks endothelial MHC class II antigen presentation to CD4+ T cells in chronic liver injury","volume":"107","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2024.111355_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2018.12.002","article-title":"Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-\u03b2-induced endothelial-mesenchymal transition and cardiac fibrosis","volume":"127","author":"Song","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7481","key":"10.1016\/j.cellsig.2024.111355_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12681","article-title":"Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis","volume":"505","author":"Ding","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2024.111355_bb0170","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","article-title":"Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis","volume":"76","author":"Qing","year":"2022","journal-title":"J. Hepatol."},{"issue":"516","key":"10.1016\/j.cellsig.2024.111355_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6296","article-title":"Selective YAP\/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis","volume":"11","author":"Haak","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellsig.2024.111355_bb0180","first-page":"1097","article-title":"Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin \u03b1v\u03b2\u2083 for staging liver fibrosis in rat model","volume":"11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061678","article-title":"Niemann-pick type C2 protein regulates free cholesterol accumulation and influences hepatic stellate cell proliferation and mitochondrial respiration function","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2024.111355_bb0190","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/FJC.0000000000000374","article-title":"Olmesartan inhibits cardiac hypertrophy in mice overexpressing renin independently of blood pressure: its beneficial effects on ACE2\/Ang(1-7)\/mas Axis and NADPH oxidase expression","volume":"67","author":"Tanno","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0200","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/hep.29734","article-title":"11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis","volume":"67","author":"Zou","year":"2018","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1016\/j.cellsig.2024.111355_bb0205","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","article-title":"Matrix metalloproteinases generate angiostatin: effects on neovascularization","volume":"161","author":"Cornelius","year":"1998","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2024.111355_bb0210","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1111\/jcmm.14543","article-title":"Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the hedgehog pathway during liver fibrosis","volume":"23","author":"Feng","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.cellsig.2024.111355_bb0215","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1016\/j.cellsig.2024.111355_bb0220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41440-018-0040-6","article-title":"The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review","volume":"41","author":"Bor\u00e9m","year":"2018","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cellsig.2024.111355_bb0225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2015.04.003","article-title":"Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways","volume":"73","author":"Zhang","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.cellsig.2024.111355_bb0230","article-title":"Suppression of Netrin-1 attenuates angiotension II-induced cardiac remodeling through the PKC\/MAPK signaling pathway","volume":"130","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacotherapy Biomed. Pharmacotherapie"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824003231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824003231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:23:32Z","timestamp":1732677812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824003231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"alternative-id":["S0898656824003231"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111355","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II depends on hippo\/YAP signaling to reprogram angiogenesis and promote liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111355"}}